Rofecoxib-induced pseudoporphyria [3]

Journal of the American Academy of Dermatology

Volumn 50, Issue 4, 2004, Pages 647-648

  Markus, Ramsey ^a   Reddick, Max E ^a   Rubenstein, Melissa C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CARISOPRODOL; FUROSEMIDE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; LEVOTHYROXINE SODIUM; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; SULFONAMIDE;

CLINICAL FEATURE; DIARRHEA; DRUG TOLERABILITY; GUILLAIN BARRE SYNDROME; HEADACHE; HUMAN; LETTER; NAUSEA; PRIORITY JOURNAL; PSEUDOPORPHYRIA; SCREENING; UPPER RESPIRATORY TRACT INFECTION;

EID: 1642411527     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2003.04.003     Document Type: Article

References (6)

1. Cummins R, Wagner-Weinder L, Paller A. Pseudoporphyria induced by celecoxib in a patient with juvenile rheumatoid arthritis. J Rheumatol 2000;27:2938-40.
2. Scott IJ, Lamb HM. Rofecoxib. Drugs 1999;58:499-505.
3. Kauer C, Sarkar R, Kanwar AJ. Fixed drug eruption to rofecoxib with cross-reactivity to sulfonamides. Dermatology 2001;203:351.
4. Grob M, Scheidegger P, Wuthrich B. Allergic skin reaction to celecoxib. Dermatology 2000;201:383.
5. Nettis E, Di Paola R, Ferrannini A, Tursi A. Tolerability of rofecoxib in patients with cutaneous adverse reactions to NSAIDs. Ann Allergy Asthma Immunol 2002;88:331-4.
6. De Silva B, Banney L, Uttley W, Luqmani R, Schofield O. Pseudoporphyria and nonsteroidal anti-inflammatory agents in children with juvenile idiopathic arthritis. Pediatr Dermatol 2000;17: 480-3.